Latest filing published 14 Aug 2026 for Caris Life Sciences, Inc.. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Jeff L. Vacirca, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Spectrum Pharmaceuticals Inc, Assertio Holdings, Inc. and Caris Life Sciences, Inc. Over a trading history stretching from 17 June 2021 to 14 August 2026, the count stands at 11 filings.
Purchases make up the whole of the open-market record (2 purchases, €32k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 8 share grants.
On 14 August 2026 came the latest disclosure, a share grant in Caris Life Sciences, Inc. The latest purchase dates back some time: it was published 858 days ago, on 12 June 2024. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations